Novartis and collaborators discover new dual-acting class of antimalarial compounds with potential to both prevent and treat malaria infections
17 November 2011 | By Novartis
Discovery of a new class of dual-acting antimalarial compounds...
List view / Grid view
17 November 2011 | By Novartis
Discovery of a new class of dual-acting antimalarial compounds...
18 October 2011 | By GlaxoSmithKline
RTS,S* reduces the risk of malaria by half...
5 May 2011 | By Sanofi-Aventis
Sanofi-aventis and MMV announced that they have signed an alliance agreement...
21 April 2011 | By Harvard School of Public Health (HSPH)
Researchers have identified several genes that may be implicated in the malaria parasite's ability to rapidly evade drug treatments...
28 June 2010 | By AstraZeneca
AstraZeneca and Medicines for Malaria Venture (MMV) today announced a collaborative agreement designed to identify novel candidate drugs for the treatment of malaria...